Dr. Mujtaba A. Qazi, MD

Dr. Qazi practices at MidAmerica Surgery Center - Chesterfield in Chesterfield, Missouri.

Dr. Qazi's NPI, 1124010434, was assigned on August 22, 2005. Dr. Qazi graduated from New York University School of Medicine in 1997. Dr. Qazi holds Missouri license 1124010434.

Dr. Qazi's primary practice is MidAmerica Surgery Center - Chesterfield, at 1815 Clarkson Road, Suite 103, Chesterfield, MO 63017. The practice phone is (636) 534-5101.

Dr. Qazi's primary practice is MidAmerica Surgery Center - Chesterfield in Chesterfield, Missouri. Dmand AI also links Dr. Qazi to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Qazi practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Qazi's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Qazi is licensed in Missouri.

CMS data shows 2,188 Medicare services from Dr. Qazi across 17 procedure codes in 2024, for 728 Medicare patients. Medicare paid $236,625 for them.

CMS counts 728 Medicare patients who saw Dr. Qazi in 2024. The largest group is 65 to 74, with 356 patients. 74% of them have high cholesterol, and 69% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Qazi's median patient age at 71, with 58% women.

In 2024, Dr. Qazi wrote 3,720 Medicare Part D claims for 890 patients. 56% of them were for generic drugs. CMS names the drug for 3,551 of them, across 39 drugs with 11 or more claims each, at $432,405 in total drug cost. In 2023, CMS named 3,016 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Qazi for performance year 2024, reported as part of a group. Dr. Qazi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 348 procedures of cataract surgery by Dr. Qazi, more than 91% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Qazi, published from 2014 to 2023. 2020 was the busiest year, with 2. The most frequent topics are Accommodation, Ocular, Lenses, Intraocular and Optics and Photonics. Dr. Qazi has published most often in Clin Ophthalmol. Dr. Qazi's most frequent co-authors are Frank W. Bowden, MD, Amit Rasik Chokshi, MD and Marguerite Bridget McDonald, MD.

Dmand AI links Dr. Qazi to 6 clinical trials. 1 is still active or recruiting. Conditions studied include Presbyopia, Refractive Errors and Conjunctivitis, Bacterial. Shire sponsors the most, 2. Open Payments lists research payments to Dr. Qazi that name 1 trial.

CMS Open Payments shows 421 general payments to Dr. Qazi from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 56% of the total. Oasis Medical, Inc. paid the most, $5,450. It also lists 8 research payments totaling $2,027 in 2024, naming 1 clinical trial.

Dr. Qazi graduated from New York University School of Medicine in 1997.